Introduction The Challenges in Peptide Oligonucleotide Conjugates development arise mainly from the complexity of combining peptides with nucleic acids into […]
Challenges in Peptide-Oligonucleotide Conjugates (POCs) Development Read More »
Introduction Peptide Oligonucleotide Conjugate Synthesis Methods have become increasingly important as peptide–oligonucleotide conjugates (POCs) gain attention in nucleic acid therapeutics,
Solid-Phase vs Solution-Phase Synthesis of Peptide-Oligonucleotide Conjugates (POCs) Read More »
Introduction: The generic pharmaceutical market in the United States and Canada is highly competitive and strictly regulated, making speed and
How CDMOs Accelerate Generic Drug Market Entry in United states and Canada Read More »
Introduction Peptide Oligonucleotide Conjugate Linker Chemistry plays a key role in how peptide carriers deliver oligonucleotides to intracellular targets. In
Linker Chemistry in Peptide-Oligonucleotide Conjugates Read More »
Introduction: A Generic Peptide drug Analytical Characterization case study highlights how advanced analytical science supports regulatory approval of complex generic
Introduction to Types of Peptide Oligonucleotide Conjugates Types of Peptide Oligonucleotide Conjugates are specialized molecular structures where therapeutic oligonucleotides are
Types of Peptide-Oligonucleotide Conjugates Used in Therapeutics Read More »
Introduction The development of synthetic peptide generics derived from recombinant DNA (rDNA) originator products presents important analytical and regulatory challenges.
Introduction: Regulatory Support for generic drugs US and Canada CDMO services play a crucial role in helping pharmaceutical companies successfully
Introduction The Peptide Mapping Study of Semaglutide is an important analytical approach used during the development of synthetic peptide generics
Introduction: When developing a generic drug product, pharmaceutical companies must decide which type of external partner best fits their needs.
CDMO vs CRO for Generic Drug Development: Which Partner Do You Need? Read More »
